folic acid has been researched along with Dermatomyositis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiheb, S; Elfatoifi, FZ; Humbert, P | 1 |
| Ghannoum, JE; Odingo, NA; Provost, N | 1 |
| Cohen, SB; Pandya, A; Sontheimer, RD; Zieglschmid-Adams, ME | 1 |
| Mowat, A | 1 |
1 review(s) available for folic acid and Dermatomyositis
| Article | Year |
|---|---|
Connective tissue diseases.
Topics: Anemia, Hemolytic; Anemia, Hypochromic; Anemia, Megaloblastic; Arthritis, Juvenile; Arthritis, Rheumatoid; Blood Volume; Collagen Diseases; Dermatomyositis; Felty Syndrome; Folic Acid; Hemolysis; Humans; Hyperplasia; Iron; Lupus Erythematosus, Systemic; Myositis; Polyarteritis Nodosa; Polymyalgia Rheumatica; Scleroderma, Systemic; Vitamin B 12 | 1972 |
3 other study(ies) available for folic acid and Dermatomyositis
| Article | Year |
|---|---|
[Infrapatellar hypertrichosis in adult dermatomyositis].
Topics: Adrenal Cortex Hormones; Aged; Biopsy; Comorbidity; Dermatomyositis; Folic Acid; Hair; Humans; Hypertrichosis; Male; Methotrexate; Patella; Skin | 2017 |
Clinico-pathologic conference: case 6.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Aspirin; Carcinoma, Squamous Cell; Carpal Tunnel Syndrome; Clonidine; Dermatomyositis; Diabetes Mellitus, Type 1; Diagnosis, Differential; Edema; Exanthema; Face; Female; Folic Acid; Hematinics; Humans; Hypertension; Hypoglycemic Agents; Hypothyroidism; Insulin; Lupus Erythematosus, Discoid; Middle Aged; Neoplasms, Unknown Primary; Paraneoplastic Syndromes; Radiotherapy, Intensity-Modulated; Skin Neoplasms; Thyroxine | 2009 |
The value of methotrexate in dermatomyositis.
Topics: Administration, Oral; Antidotes; Aspartate Aminotransferases; Biopsy; Dermatologic Agents; Dermatomyositis; Folic Acid; Hematinics; Humans; Leucovorin; Liver; Methotrexate; Risk Factors | 1998 |